Literature DB >> 20200278

H-2Ld class I molecule protects an HIV N-extended epitope from in vitro trimming by endoplasmic reticulum aminopeptidase associated with antigen processing.

Susana Infantes1, Yolanda Samino, Elena Lorente, Mercedes Jiménez, Ruth García, Margarita Del Val, Daniel López.   

Abstract

In the classical MHC class I Ag presentation pathway, antigenic peptides derived from viral proteins by multiple proteolytic cleavages are transported to the endoplasmic reticulum lumen and are then exposed to ami-nopeptidase activity. In the current study, a long MHC class I natural ligand recognized by cytotoxic T lymphocytes was used to study the kinetics of degradation by aminopeptidase. The in vitro data indicate that this N-extended peptide is efficiently trimmed to a 9-mer, unless its binding to the MHC molecules protects the full-length peptide.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20200278     DOI: 10.4049/jimmunol.0901560

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  Critical Role of Interdomain Interactions in the Conformational Change and Catalytic Mechanism of Endoplasmic Reticulum Aminopeptidase 1.

Authors:  Athanasios Stamogiannos; Zachary Maben; Athanasios Papakyriakou; Anastasia Mpakali; Paraskevi Kokkala; Dimitris Georgiadis; Lawrence J Stern; Efstratios Stratikos
Journal:  Biochemistry       Date:  2017-03-02       Impact factor: 3.162

Review 2.  Antigenic peptide trimming by ER aminopeptidases--insights from structural studies.

Authors:  Efstratios Stratikos; Lawrence J Stern
Journal:  Mol Immunol       Date:  2013-03-29       Impact factor: 4.407

Review 3.  Molecular pathways for antigenic peptide generation by ER aminopeptidase 1.

Authors:  Anastasia Mpakali; Zachary Maben; Lawrence J Stern; Efstratios Stratikos
Journal:  Mol Immunol       Date:  2018-04-17       Impact factor: 4.407

Review 4.  Post-proteasomal and proteasome-independent generation of MHC class I ligands.

Authors:  Peter van Endert
Journal:  Cell Mol Life Sci       Date:  2011-03-10       Impact factor: 9.261

5.  Structural Basis for Antigenic Peptide Recognition and Processing by Endoplasmic Reticulum (ER) Aminopeptidase 2.

Authors:  Anastasia Mpakali; Petros Giastas; Nikolas Mathioudakis; Irene M Mavridis; Emmanuel Saridakis; Efstratios Stratikos
Journal:  J Biol Chem       Date:  2015-09-17       Impact factor: 5.157

6.  A systematic re-examination of processing of MHCI-bound antigenic peptide precursors by endoplasmic reticulum aminopeptidase 1.

Authors:  George Mavridis; Richa Arya; Alexander Domnick; Jerome Zoidakis; Manousos Makridakis; Antonia Vlahou; Anastasia Mpakali; Angelos Lelis; Dimitris Georgiadis; Robert Tampé; Athanasios Papakyriakou; Lawrence J Stern; Efstratios Stratikos
Journal:  J Biol Chem       Date:  2020-03-17       Impact factor: 5.157

7.  Structural basis for antigenic peptide precursor processing by the endoplasmic reticulum aminopeptidase ERAP1.

Authors:  Tina T Nguyen; Shih-Chung Chang; Irini Evnouchidou; Ian A York; Christos Zikos; Kenneth L Rock; Alfred L Goldberg; Efstratios Stratikos; Lawrence J Stern
Journal:  Nat Struct Mol Biol       Date:  2011-04-10       Impact factor: 15.369

Review 8.  The Role of Conformational Dynamics in Antigen Trimming by Intracellular Aminopeptidases.

Authors:  Athanasios Papakyriakou; Efstratios Stratikos
Journal:  Front Immunol       Date:  2017-08-07       Impact factor: 7.561

9.  Diversity of natural self-derived ligands presented by different HLA class I molecules in transporter antigen processing-deficient cells.

Authors:  Elena Lorente; Susana Infantes; Eilon Barnea; Ilan Beer; Alejandro Barriga; Noel García-Medel; Fátima Lasala; Mercedes Jiménez; Arie Admon; Daniel López
Journal:  PLoS One       Date:  2013-03-26       Impact factor: 3.240

10.  Concerted in vitro trimming of viral HLA-B27-restricted ligands by human ERAP1 and ERAP2 aminopeptidases.

Authors:  Elena Lorente; Alejandro Barriga; Carolina Johnstone; Carmen Mir; Mercedes Jiménez; Daniel López
Journal:  PLoS One       Date:  2013-11-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.